ZURICH – Swiss drugmaker Novartis has ended a contract with a firm linked to U.S. President Donald Trump’s lawyer, Michael Cohen, saying it was now seen as a mistake.
Novartis, which has not been accused of any illegal activity, made payments totalling nearly $1.2 million to the U.S. firm. It was approached last year by the U.S. special counsel, who wanted to know about the money while probing potential meddling in the 2016 U.S. election.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.